Simplex Trading’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Simplex Trading’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,051	Closed	-$288K	–	9900
2024 Q2	$288K	Buy	+7,051	New	+$294K	﹤0.01%	4289
2023 Q2	–	Sell	-9,848	Closed	-$302K	–	10210
2023 Q1	$240K	Buy	+9,848	New	+$289K	﹤0.01%	4117
2022 Q3	–	Sell	-12,491	Closed	-$372K	–	11128
2022 Q2	$330K	Buy	+12,491	New	+$355K	﹤0.01%	3979

Other funds holding CERE

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Simplex Trading's CERE Position: Q3 2024 in Review

Simplex Trading sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 7,051 shares — an estimated $288K sold.

Simplex Trading first reported a position in CERE in Q2 2022 and held it in 3 quarters. The position peaked at $330K in Q2 2022. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Simplex Trading reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Simplex Trading sold 7,051 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $288K.
Simplex Trading first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
Simplex Trading's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $330K in Q2 2022.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.